Boston Scientific, Guidant to pay $30M settlement

The Justice Department says Boston Scientific Corp. and its Guidant subsidiaries will pay $30 million to settle allegations that Guidant knowingly sold defective heart devices that health care facilities implanted in Medicare patients from 2002 to 2005.

Boston Scientific is headquartered in Natick, Mass., and acquired Guidant in 2006.

The Justice Department says that while Guidant took corrective action to fix the defects, the company continued selling its remaining stock of defective versions of the devices. In addition, the government alleged that as Guidant learned about the cause of the defect, it took steps to hide the problem from patients, doctors and the Food and Drug Administration, which regulates medical devices.

The devices are used in patients at risk of cardiac arrest due to an irregular heartbeat.

© 2013 The Associated Press. All rights reserved.

Citation: Boston Scientific, Guidant to pay $30M settlement (2013, October 17) retrieved 19 March 2024 from https://medicalxpress.com/news/2013-10-boston-scientific-guidant-30m-settlement.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

FDA proposes new rules for heart defibrillators

 shares

Feedback to editors